Finished
Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton
NCT06225830 · Albert Einstein Healthcare Network · Updated 30 Sept 2026
- What is being tested
- Eksobionics Eksoskeleton NR
- For
- Parkinson Disease
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 13 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 4 June 2024, ends 24 Aug 2026. Registered 26 Jan 2024.
- Results
- None posted yet.
In the researchers' words
The goal of this study is to see how well therapy with the Eksobionic Exoskeleton (Esko) works for people with Parkinson's disease (PWPD). Esko is a robotic device that provides high repetition and intensity training. The investigators will examine its impact on walking, balance, and quality of life before, during and after an eight-week intervention program. The results will lay the groundwork for future trials, potentially leading to long-term improvements in mobility and quality of life for PWPD.
Sites
- Jefferson Moss-Magee Rehabilitation - Elkins ParkElkins Park, Pennsylvania, United States